Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.17+0.00 (+1.95%)
Close on Nov 20, 2026Market cap $415.59KP/E –Yield –
Arcadia Biosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Arcadia Biosciences's free cash flow for the twelve months ending Dec 31, 2025 was -$4.70M. For fiscal 2025 it was -$4.70M. The highest annual figure on record is -$4.70M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.70M | – |
| FY2024 | Dec 31, 2024 | -$9.64M | – |
| FY2023 | Dec 31, 2023 | -$15.30M | – |
| FY2022 | Dec 31, 2022 | -$14.05M | – |
| FY2021 | Dec 31, 2021 | -$26.88M | – |
| FY2020 | Dec 31, 2020 | -$32.55M | – |
| FY2019 | Dec 31, 2019 | -$18.68M | – |
| FY2018 | Dec 31, 2018 | -$13.88M | – |
| FY2017 | Dec 31, 2017 | -$14.04M | – |
| FY2016 | Dec 31, 2016 | -$17.29M | – |
| FY2015 | Dec 31, 2015 | -$15.26M | – |
| FY2014 | Dec 31, 2014 | -$14.94M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$822.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$257.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.03M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.21M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.46M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.22M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.89M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.47M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.37M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.75M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.47M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.19M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.05M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.21M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.05M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.61M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.32M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.69M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.06M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.86M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.04M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.69M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.38M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.39M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.59M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.29M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.96M | – |
See a number that looks wrong?